ArticleiScience2026
Key genes and pathways of pulmonary hypertension identified by integrating bulk and single-cell RNA sequencing.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary hypertension (PH) is a progressive vascular disease, yet the underlying cell-type-specific molecular networks and diagnostic biomarkers remain incompletely defined. Integrating single-cell and bulk transcriptomics, we identified 14 pulmonary cell types in PH, with smooth muscle cells (SMCs) as a central communication hub interacting with monocytes and macrophages. High-dimensional weighted gene co-expression network analysis (hdWGCNA) revealed 4 SMC modules enriched in extracellular matrix organization, TGF-β, and HIF-1 pathways. A five-gene diagnostic signature distinguished PH from controls with an area under the curve of 0.895. Immune infiltration and enrichment analysis showed that activated CD4 memory T cells, activated dendritic cells, and resting mast cells increased in the PH group, while angiogenesis and epithelial-mesenchymal transition pathway were upregulated. In hypoxic human pulmonary artery SMCs, milk fat globule-epidermal growth factor-8 (MFGE8), secreted frizzled-related protein 2 (SFRP2), S100 calcium-binding protein A11 (S100A11), and procollagen C-endopeptidase enhancer 2 (PCOLCE2) were upregulated, and their knockdown suppressed proliferation, highlighting them as potential biomarkers and drivers of vascular remodeling, revealing a new molecular mechanism for PH and providing insights for potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.